Skip to main content

Table 4 Effect of BMI in subjects with, and without, PCOS: Metabolic parameters

From: Effect of body mass index (BMI) on phenotypic features of polycystic ovary syndrome (PCOS) in Singapore women: a prospective cross-sectional study

Variables

Patient category

BMI

Mean ± SD

Model A

Model B

Model C

Fold change

Adjusted difference (95% CI)

Fold change

Adjusted difference (95% CI)

Fold change

Adjusted difference (95% CI)

HOMA-IR

Healthy

Normal

1.29 ± 0.15

1.0

Ref

    

High

2.20 ± 0.19

1.71

0.68 (0.01, 1.35)*

1.0

Ref

  

PCOS

Normal

1.23 ± 0.24

0.95

0.05 (− 0.74, 0.84)

0.56

− 0.63 (− 1.53, 0.27)

1.0

Ref

High

3.53 ± 0.22

2.74

1.48 (0.71. 2.25)***

1.60

0.80 (− 0.03, 1.64)

2.87

1.43 (0.48, 2.38)***

Cholesterol (mmol/L)

Healthy

Normal

4.63 ± 0.07

1.0

Ref

    

High

5.10 ± 0.08

1.10

0.42 (0.09, 0.74)**

1.0

Ref

  

PCOS

Normal

4.71 ± 0.11

1.02

0.09 (− 0.30, 0.48)

0.92

− 0.33 (− 0.77, 0.11)

1.0

Ref

High

4.96 ± 0.10

1.07

0.16 (− 0.21, 0.54)

0.97

− 0.25 (− 0.66, 0.16)

1.05

0.08 (− 0.39, 0.54)

Triglycerides (mmol/L)

Healthy

Normal

0.80 ± 0.06

1.0

Ref

    

High

1.30 ± 0.07

1.63

0.35 (0.15, 0.55)***

1.0

Ref

  

PCOS

Normal

0.81 ± 0.09

1.01

0.03 (− 0.21, 0.27)

0.62

− 0.32 (− 0.59, − 0.05)*

1.0

Ref

High

1.24 ± 0.08

1.55

0.36 (0.13, 0.59)***

0.95

0.01 (− 0.24, 0.26)

1.53

0.33 (0.04, 0.61)*

HDL (mmol/L)

Healthy

Normal

1.59 ± 0.03

1.0

Ref

    

High

1.35 ± 0.03

0.85

− 0.21 (− 0.36, − 0.07)***

1.0

Ref

  

PCOS

Normal

1.63 ± 0.04

1.03

0.00 (− 0.17, 0.17)

1.21

0.21 (0.01, 0.40)*

1.0

Ref

High

1.28 ± 0.04

0.81

− 0.33 (− 0.50, − 0.17)***

0.95

− 0.12 (− 0.30, 0.06)

0.74

− 0.33 (− 0.53, − 0.12)***

LDL (mmol/L)

Healthy

Normal

2.66 ± 0.06

1.0

Ref

    

High

3.20 ± 0.08

1.20

0.45 (0.17, 0.74)***

1.0

Ref

  

PCOS

Normal

2.72 ± 0.10

1.02

0.15 (− 0.19, 0.49)

0.85

− 0.30 (− 0.69, 0.08)

1.0

Ref

High

3.12 ± 0.09

1.18

0.37 (0.04, 0.70)*

0.98

− 0.08 (− 0.44, 0.27)

1.15

0.22 (− 0.19, 0.62)

  1. HOMA‐IR, homoeostatic model assessment‐insulin resistance; HDL, high-density lipoprotein; LDL, low-density lipoprotein